Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir

Lipoatrophy modestly improves when the thymidine analogue nucleoside reverse transcriptase inhibitor (tNRTI) is removed. In vitro, uridine (NucleomaxX(®); Pharma Nord, Vojens, Denmark) reversed tNRTI mitochondrial toxicity. All patients had lipoatrophy on a tNRTI-containing regimen with HIV RNA

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antiviral therapy 2012-01, Vol.17 (2), p.347-353
Hauptverfasser: MCCOMSEY, Grace A, O'RIORDAN, Maryann, CHOI, Julia, LIBUTTI, Daniel, ROWE, David, STORER, Norma, HARRILL, Danielle, GERSCHENSON, Mariana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lipoatrophy modestly improves when the thymidine analogue nucleoside reverse transcriptase inhibitor (tNRTI) is removed. In vitro, uridine (NucleomaxX(®); Pharma Nord, Vojens, Denmark) reversed tNRTI mitochondrial toxicity. All patients had lipoatrophy on a tNRTI-containing regimen with HIV RNA
ISSN:1359-6535
2040-2058
DOI:10.3851/IMP1928